Correlation Between Recursion Pharmaceuticals and 001192AH6

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and 001192AH6 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and 001192AH6 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and AGL CAP P, you can compare the effects of market volatilities on Recursion Pharmaceuticals and 001192AH6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of 001192AH6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and 001192AH6.

Diversification Opportunities for Recursion Pharmaceuticals and 001192AH6

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between Recursion and 001192AH6 is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and AGL CAP P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AGL CAP P and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with 001192AH6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AGL CAP P has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and 001192AH6 go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and 001192AH6

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 3.98 times more return on investment than 001192AH6. However, Recursion Pharmaceuticals is 3.98 times more volatile than AGL CAP P. It trades about 0.02 of its potential returns per unit of risk. AGL CAP P is currently generating about 0.02 per unit of risk. If you would invest  884.00  in Recursion Pharmaceuticals on September 12, 2024 and sell it today you would lose (138.00) from holding Recursion Pharmaceuticals or give up 15.61% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy58.01%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  AGL CAP P

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
AGL CAP P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AGL CAP P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for AGL CAP P investors.

Recursion Pharmaceuticals and 001192AH6 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and 001192AH6

The main advantage of trading using opposite Recursion Pharmaceuticals and 001192AH6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, 001192AH6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 001192AH6 will offset losses from the drop in 001192AH6's long position.
The idea behind Recursion Pharmaceuticals and AGL CAP P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges